Congratulations to the IDIGH Program PIs who have received grants to understand and fight COVID-19:

MI4 Emergency COVID—19 Research Funding (Round 2)

*IDIGH PIs in bold

Drs. Inés Colmegna, Amal Bessissow and David Meger titled: Use of Technology to Improve Effects of Social Isolation on Hospitalized COVID-19 Patients (TIES-COVID)

Drs. Patricia Fontela and Jesse Papenburg titled: A Multi-Centre, Randomized, Open-Label, Controlled Clinical Trial of the Safety and Efficacy of Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Children in Canada (CATCO-Kids). Supported by the Montreal Children’s Hospital Foundation

Dr. Bertrand Lebouché titled: Detection of Anti- SARS-CoV-2 Antibodies in Sera from COVID19 Patients

Drs. Greg Matlashewski, Matthew Cheng and Momar Ndao titled: Detection of Anti- SARS-CoV-2 Antibodies in Sera from COVID19 Patients

Drs. Momar Ndao and Michael Reed titled: COVID-19 Vaccines - Novel Approaches to Tackle a Novel Disease

For more information on this grant and to view the full list of grant recipients, click here.

Contact

IDIGH Program
Research Institute of McGill University Health Centre
Glen site, Block E, Room EM3-3211
1001 Boul Décarie
Montreal, QC H4A 3J1

Program Manager

Eric Beliveau, Ph.D
eric.beliveau@mail.mcgill.ca
514-934-1934 ext 76170

Program Assistant

Joanne Krief
joanne.krief@mail.mcgill.ca
514-934-1934 ext 76174